Category Archives: Zocor

Featured Stories

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

Post -Tonsillectomy Morphine Life-Threatening in Children

Post -Tonsillectomy Morphine can be Life-Threatening in Children, Study Finds

A new study published in Pediatrics suggests that morphine can result in life-threatening respiratory problems when given to children after a tonsillectomy.

Read More

64 More Plavix Patients File Suit Over Bleeding Side Effects

Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, such as the heart attacks and strokes it is ...

Read More

Exploding Tanks Kill Jeep Drivers 18 months after Recall

Exploding Gas Tanks Continue to Kill Jeep Drivers 18 months after Recall

Chrysler recalled Jeeps with exploding gas tanks more than 18 months ago, but 1 million+ of these vehicles have not been fixed as the death toll continues to rise.

Read More

Transvaginal Mesh Lawsuit Trial

$5.5 Million Awarded to Plaintiffs in First Transvaginal Mesh Lawsuit Trial

An award of $5.5 million has been made in the first trial over a transvaginal mesh lawsuit. The jury found against medical device maker, C.R. Bard, and its Avaulta Plus transvaginal mesh. The jury agreed that Bard’s Avaulta Plus transvaginal mesh caused numerous and painful injuries in a California woman. ...

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business

Medtronic’s spinal division continues to take a huge hit thanks to the controversy surrounding its Infuse Bone Graft product. According to a report from MassDevice.com, the company’s latest earnings report stated that the division saw Infuse sales decline 26% in the first quarter of 2012, and now Medtronic is talking ...

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

Two Men Found Dead of Carbon Monoxide Poisoning

Two Men Found Dead of Carbon Monoxide Poisoning at Long Island, New York Auto Shop

Two men were found dead of apparent carbon monoxide poisoning in a Holbrook, New York, auto-detailing shop Thursday night, Suffolk County police say.

Read More

Study Shows Increased Risk of Type 2 Diabetes for Statin Users

Increased Risk of Type 2 Diabetes for Statin Users

A new study from Finland has confirmed previous findings about a link between the use of cholesterol-lowering statin drugs and higher risk of Type 2 diabetes. This study, published in the journal Diabetologia, avoided some of the limitations of earlier … Continue reading

Posted in Health Concerns, Pharmaceuticals, Zocor | Tagged , , , |

Statins May Raise Risk of Cataracts

New Canadian research shows that cholesterol-lowering statin drugs may raise the risk of developing cataracts, a clouding of the lens of the eye. While statins such as Zocor (simvastatin), Crestor (rosuvastatin), and Lipitor (atorvastatin) protect many people from heart attack … Continue reading

Posted in Crestor, Health Concerns, Pharmaceuticals, Zocor |

Statin Drugs Increase Risk of Diabetes

According to a study just published online in the medical journal the Lancet, cholesterol-lowering statin drugs can directly increase the risk of diabetes. While statins have previously been associated with higher rates of Type 2 diabetes, it was not clear … Continue reading

Posted in Birth Defects, Crestor, Health Concerns, Pharmaceuticals, Zocor |

New Research Identifies Serious Design Flaws in Many Animal-Based Drug Studies

animal-testing-flawed-statin-drugs

Recently published research reports serious design flaws in many of the pharmaceutical studies involving animals that precede drug trials in humans. A research team led by pharmacologist Lisa Bero of the University of California, San Francisco, analyzed animal studies of … Continue reading

Posted in Crestor, Pharmaceuticals, Zocor |

Study: Statins May Reduce Exercise Benefits in Overweight, Obese Adults

Statins_Affect_Excercise

A new study has found that statins, used to lower blood cholesterol levels, may reduce exercise benefits for overweight adults. Statins rank among the best selling drugs in the world and are typically prescribed to people with obesity, diabetes, and … Continue reading

Posted in Crestor, Pharmaceuticals, Zocor |

Study: High-Dose Statins Linked to Acute Kidney Injury

A recent BMJ article reviewed the connection between statin medications and kidney damage. The just-published article reviewed data from over 2 million patient records dated from 1997 to 2008, said the Drug Safety Monitor. Records originated from Canadian provinces and … Continue reading

Posted in Crestor, Pharmaceuticals, Zocor |

Age-Related Cataracts Linked to Statin Use

People who use statins to lower their cholesterol may face a higher risk of developing age-related cataracts, according to a new study that appears in the August issue of Optometry and Vision Science.  According to the study, the association between … Continue reading

Posted in Crestor, Pharmaceuticals, Zocor | Tagged |

More Potent Statins Linked to Muscle Damage

Statin drugs prescribed to lower cholesterol levels are more likely to cause severe muscle injuries when taken at higher doses or when more potent forms of the drug are used. According to a ScienceDaily.com report on a new study from … Continue reading

Posted in Pharmaceuticals, Zocor | Tagged |

Statins May Leave Patients Fatigued, Study Finds

Cholesterol-lowering statins may leave patients fatigued, according to a new study. Statins are a class of prescription drugs used in combination with diet and exercise to lower the blood levels of low-density lipoprotein (LDL) cholesterol—so-called bad cholesterol. The research found … Continue reading

Posted in Pharmaceuticals, Zocor | Tagged |

FDA Warns Of Statin Interactions With HIV, Hepatitis C Drugs

The U.S. Food and Drug Administration (FDA) issued a warning concerning statin interactions with HIV and hepatitis C medications. The notification involved interactions between protease inhibitors and certain statin drugs, including Lipitor (Atorvastatin), Mevacor (Lovastatin), Crestor (Rosuvastatin), and Zocor (Simvastatin). … Continue reading

Posted in Crestor, Pharmaceuticals, Zocor |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.